Stay updated with breaking news from Safety Data Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™...
Previously Announced Statistically Significant Interim Analysis Established Proof of Concept Efficacy and Safety Data Expected on the Full Set of Subjects in Third Quarter 2022 NEW HAVEN, Conn.,... | March 15, 2022
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™...